Express Scripts (ESRX) So-Called 'Price War' Comments Taken Out of Context - Analyst (GILD) (ABBV)

Go back to Express Scripts (ESRX) So-Called 'Price War' Comments Taken Out of Context - Analyst (GILD) (ABBV)

UPDATE: AbbVie Inc. (ABBV) Stock Gains

December 10, 2013 12:47 PM EST

(Updated - December 10, 2013 1:00 PM EST)

AbbVie Inc. (NYSE: ABBV) stock gained ground on Tuesday. The move relates to news Express Scripts (Nasdaq: ESRX) could start a pricing war if competitors accept lower prices on Gilead's (Nasdaq:... More

Express Scripts (ESRX) Could Go With Cheaper Alternative to Gilead's (GILD) HCV Treatment

December 10, 2013 12:42 PM EST

Express Scripts (Nasdaq: ESRX) could wage a pricing war if competitors accept lower prices on Gilead's (Nasdaq: GILD) hepatitis C (HCV) treatment.

According to Bloomberg, Express Scripts' chief medical officer, Steven Miller, commented, If... More